Glycerin
Active ingredient · 2 therapeutic classes
Sold as Optase · DCH Hemorrhoidal · No More Products · Bliss GVS Children · Pranicura 5
- Drug class
- Enemas
- Availability
- Over-the-counter
- Routes
- Ophthalmic, Rectal, Transdermal, Topical
- Markets covered
- 2
- Products on record
- 33
- FDA reports (12 mo)
- 1,235
Overview
Plain-language summary, compiled from the cited regulatory records
Glycerin is an active ingredient classified as an enema [1]. It is approved for the temporary relief of burning and irritation associated with eye dryness [1]. Additionally, it is indicated for the temporary relief of discomfort from minor eye irritations or exposure to environmental factors like wind or sun [1]. Glycerin also acts as a protectant to prevent further irritation or to alleviate eye dryness [1].
This ingredient is available under various brand names, including OASIS Tears Lubricant Eye and Sunmark Dry Eye Relief [1]. In the past 12 months, there have been 1235 adverse event reports associated with products containing glycerin [2]. The most frequently reported reactions include eye pain, the perception of the drug being ineffective, and eye irritation [2]. Other reported issues include off-label use and problems with the product container [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 24 | February 10, 2026 |
| GB United Kingdom | MHRA | 9 | March 27, 2026 |
USUnited States· FDA
24 products
Uses
Uses For the temporary relief of burning and irritation due to dryness of the eye For the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun For use as a protectant against further irritation or to relieve dryness of the eye
How to take
GBUnited Kingdom· MHRA
9 products
Uses
For the relief of irritating, tickling dry coughs and sore throats.
How to take
Drug interactions
Known interactions involving Glycerin. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 00071697-4ac6-49… · revised January 22, 2025 [PDF]
- [2]MHRA (UK) · PL000140307 · revised July 18, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.